William Dameshek 2167323 207413656 2008-04-22T18:21:54Z ASH 50 Anniversary 6950779 '''William Dameshek''' (1900-1969) was an [[United States|American]] [[hematology|hematologist]]. Trained at [[Harvard]], he was the founder of ''[[Blood (journal)|Blood]]'', the prime core clinical journal of hematology, in [[1946]]. He is also credited with describing the concept of [[myeloproliferative disease]]s in [[1951]]. In addition, he participated in the first studies of [[nitrogen mustard]] in various [[hematological malignancy|hematological malignancies]], widely considered the first uses of [[chemotherapy]] in malignant diseases. Dr. Dameshek served as president of the [[American Society of Hematology]] (ASH) in 1964. He made numerous contributions to ASH as well as the field of hematology and was the first eidtor of its journal ''[[Blood (journal)|Blood]]''. Given Dr. Dameshek's accomplishments, ASH has named the Dameshek Prize in his honor. Each year the Dameshek Prize is awarded to indivdual who has made an outstanding contribuiton in hematology. == External Links == The American Society of Hematology (http://www.hematology.org/) ==References== * Goodman LS, Wintrobe MM, Dameshek W, Goodman MJ, Gilman A and McLennan MT. ''Nitrogen mustard therapy. Use of methyl-bis(beta-chloroethyl)amine hydrochloride and tris(beta-chloroethyl)amine hydrochloride for Hodgkin's disease, lymphosarcoma, leukemia, and certain allied and miscellaneous disorders.'' J Am Med Assoc 1946;105:475-476. Reprinted in JAMA 1984;251:2255-61. PMID 6368885. {{DEFAULTSORT:Dameshek, William}} [[Category:American physicians]] [[Category:Hematologists]] [[Category:1900 births]] [[Category:1969 deaths]] {{US-med-bio-stub}} [[pl:William Dameshek]]